🇺🇸 FDA
Patent

US 11358977

Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels

granted A61PA61P29/00

Quick answer

US patent 11358977 (Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P29/00